Disease_category,Disease,Protein,Protein_definition,Method,Nb_SNP,OR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",FURIN,Furin,Inverse variance weighted,6,1.02 [0.90-1.16],0.718772250006386
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CCL23,C-C motif chemokine 23,Inverse variance weighted,23,0.99 [0.93-1.06],0.785920654932276
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",GUCA2A,Guanylin,Inverse variance weighted,16,0.99 [0.90-1.09],0.877497903809238
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,5,0.95 [0.76-1.18],0.623753093825
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,27,1.03 [0.88-1.20],0.721734737909427
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,28,0.99 [0.95-1.04],0.781312908837047
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",HNMT,Histamine N-methyltransferase,Inverse variance weighted,32,1.01 [0.97-1.05],0.585974246445764
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",SCG2,Secretogranin-2,Inverse variance weighted,3,1.03 [0.48-2.21],0.949711425819944
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",REG4,Regenerating islet-derived protein 4,Inverse variance weighted,19,0.96 [0.78-1.19],0.718643383049486
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",MDK,Midkine,Inverse variance weighted,19,1.02 [0.89-1.16],0.795881355763953
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,4,1.03 [0.91-1.17],0.592544675830931
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,30,0.93 [0.87-0.99],0.0243135170751255
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",FAM3B,Protein FAM3B,Inverse variance weighted,26,0.98 [0.93-1.03],0.4194907951095
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",RTBDN,Retbindin,Inverse variance weighted,5,0.91 [0.74-1.12],0.373707095012638
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Inverse variance weighted,2,1.12 [0.90-1.38],0.307730333582277
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,1.02 [0.80-1.32],0.849087906446545
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,17,1.04 [0.97-1.11],0.312727483530173
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CCN1,CCN family member 1,Inverse variance weighted,9,1.37 [1.03-1.81],0.0288082552515678
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CPM,Carboxypeptidase M,Inverse variance weighted,23,1.14 [1.00-1.28],0.0428034529793395
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",VWC2,Brorin,Inverse variance weighted,35,1.05 [0.99-1.11],0.100744822831206
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,0.92 [0.60-1.41],0.700059123920605
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CHGA,Chromogranin-A,Inverse variance weighted,8,1.00 [0.90-1.12],0.988718686088634
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",COLEC12,Collectin-12,Inverse variance weighted,13,0.93 [0.82-1.07],0.321102346875062
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",BCHE,Cholinesterase,Inverse variance weighted,67,1.00 [0.96-1.05],0.83317553766538
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CCL22,C-C motif chemokine 22,Inverse variance weighted,13,0.99 [0.87-1.11],0.818954771707494
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CD59,CD59 glycoprotein,Inverse variance weighted,8,1.01 [0.92-1.12],0.814471927936123
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",ACE2,Angiotensin-converting enzyme 2,Inverse variance weighted,11,0.96 [0.77-1.19],0.705219965045898
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,1.15 [0.67-1.99],0.613465780551405
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,11,0.99 [0.89-1.10],0.846635824201091
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,1.08 [0.79-1.47],0.640415608724735
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",XG,Glycoprotein Xg,Inverse variance weighted,2,0.91 [0.56-1.48],0.710217290708565
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",SLC39A5,Zinc transporter ZIP5,Inverse variance weighted,16,1.13 [0.94-1.37],0.190378545786959
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,26,1.02 [0.96-1.08],0.506193731721379
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CD300E,CMRF35-like molecule 2,Inverse variance weighted,36,0.96 [0.91-1.02],0.168201501649775
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",NECTIN2,Nectin-2,Inverse variance weighted,8,0.92 [0.75-1.14],0.444451181608252
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",PRSS2,Trypsin-2,Inverse variance weighted,22,0.94 [0.83-1.06],0.282509460424218
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",DMP1,Dentin matrix acidic phosphoprotein 1,Inverse variance weighted,17,0.84 [0.73-0.96],0.0098574121561147
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,1.10 [1.00-1.22],0.0572158527328508
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CDH2,Cadherin-2,Inverse variance weighted,21,0.99 [0.78-1.24],0.914767566896386
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,15,0.98 [0.89-1.09],0.743750129645205
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",LMNB2,Lamin-B2,Inverse variance weighted,9,1.04 [0.86-1.25],0.706627537808514
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",LGALS3,Galectin-3,Inverse variance weighted,42,1.00 [0.95-1.05],0.926996037151201
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CCL16,C-C motif chemokine 16,Inverse variance weighted,26,1.03 [1.00-1.07],0.0903044444488495
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,40,1.06 [0.98-1.15],0.151418928144626
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,55,1.01 [0.98-1.05],0.471004319153317
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",AGRN,Agrin,Inverse variance weighted,31,1.01 [0.95-1.09],0.699587664217513
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,28,0.99 [0.95-1.03],0.479739051113464
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,30,1.04 [0.96-1.11],0.334821228077252
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",MXRA8,Matrix remodeling-associated protein 8,Inverse variance weighted,11,0.94 [0.78-1.12],0.477670162027567
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",GDF15,Growth/differentiation factor 15,Inverse variance weighted,14,0.98 [0.85-1.12],0.724520878899937
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",HEG1,Protein HEG homolog 1,Inverse variance weighted,18,0.96 [0.83-1.11],0.572064336148427
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",MMP7,Matrilysin,Inverse variance weighted,15,1.01 [0.94-1.09],0.74004177902957
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",FABP4,"Fatty acid-binding protein, adipocyte",Inverse variance weighted,2,1.01 [0.81-1.27],0.910548163398844
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,17,0.94 [0.82-1.07],0.34888572041806
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",TCN2,Transcobalamin-2,Inverse variance weighted,66,0.98 [0.94-1.01],0.202966111269767
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CFI,Complement factor I,Inverse variance weighted,8,1.03 [0.92-1.16],0.580275407286616
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,14,0.94 [0.83-1.06],0.337291665125345
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CNTN3,Contactin-3,Inverse variance weighted,34,0.94 [0.87-1.02],0.149590180525403
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",NUCB2,Nucleobindin-2,Inverse variance weighted,28,1.00 [0.93-1.07],0.994384549307292
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,18,1.07 [0.96-1.21],0.223016761767039
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,0.90 [0.77-1.06],0.213835949463488
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,30,1.04 [0.97-1.10],0.266282799516921
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,22,1.05 [0.94-1.17],0.379296006400091
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",LDLR,Low-density lipoprotein receptor,Inverse variance weighted,18,1.24 [1.04-1.47],0.0174620480348755
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",SCLY,Selenocysteine lyase,Inverse variance weighted,7,1.05 [0.94-1.18],0.40158074609754
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",DTNB,Dystrobrevin beta,Inverse variance weighted,4,1.04 [0.66-1.62],0.880139299833676
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",ADM,Pro-adrenomedullin,Inverse variance weighted,4,0.91 [0.80-1.04],0.1567658669097
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",SCARB2,Lysosome membrane protein 2,Inverse variance weighted,17,1.06 [0.95-1.18],0.315727000776877
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,6,0.84 [0.76-0.94],0.0014257384924162
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,5,1.10 [0.89-1.35],0.374732538241692
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",TFF1,Trefoil factor 1,Inverse variance weighted,14,1.04 [0.96-1.12],0.374499923621344
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,18,0.94 [0.88-1.01],0.105932999438566
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,8,0.91 [0.70-1.18],0.477375343692635
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CD302,CD302 antigen,Inverse variance weighted,17,0.95 [0.88-1.03],0.203932239169867
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,29,0.96 [0.89-1.04],0.367364478130836
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Inverse variance weighted,3,1.11 [0.78-1.57],0.57183677771279
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,21,1.76 [1.29-2.40],0.0003610350778952
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,11,0.91 [0.74-1.14],0.421194199488282
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,0.73 [0.14-3.76],0.704099498334394
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,5,1.05 [0.70-1.57],0.813438369672224
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",EFNA1,Ephrin-A1,Inverse variance weighted,15,0.98 [0.89-1.09],0.757209842920091
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",MME,Neprilysin,Inverse variance weighted,49,1.01 [0.95-1.07],0.709063170952673
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",ANGPT2,Angiopoietin-2,Inverse variance weighted,11,1.11 [0.97-1.27],0.137220562780897
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",RNASE1,Ribonuclease pancreatic,Inverse variance weighted,6,0.99 [0.88-1.10],0.791253133700529
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",PGF,Placenta growth factor,Inverse variance weighted,8,1.09 [0.86-1.38],0.480626461139572
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,20,0.98 [0.89-1.07],0.630147359934284
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,11,0.99 [0.88-1.12],0.873147978108718
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",ADGRG2,Adhesion G-protein coupled receptor G2,Inverse variance weighted,8,0.99 [0.81-1.21],0.948048763208276
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",OMD,Osteomodulin,Inverse variance weighted,15,1.08 [0.96-1.22],0.177109449486367
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",REN,Renin,Inverse variance weighted,12,1.02 [0.94-1.11],0.616860264431852
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",LEP,Leptin,Inverse variance weighted,4,1.16 [0.52-2.59],0.712939403627166
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,41,1.00 [0.96-1.03],0.902514212825763
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",ANG,Angiogenin,Inverse variance weighted,25,1.04 [0.97-1.12],0.2222188800816
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",PAMR1,Inactive serine protease PAMR1,Inverse variance weighted,30,1.01 [0.95-1.07],0.801239614063608
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,1.15 [1.03-1.29],0.0141458461136215
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,19,0.99 [0.93-1.05],0.74081857927028
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,66,0.99 [0.96-1.02],0.538847160365917
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",FUOM,Fucose mutarotase,Inverse variance weighted,6,1.02 [0.83-1.25],0.83956578260187
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",ANGPTL3,Angiopoietin-related protein 3,Inverse variance weighted,15,1.03 [0.87-1.23],0.701688046760281
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",HYAL1,Hyaluronidase-1,Inverse variance weighted,23,1.07 [0.99-1.16],0.0947255564348384
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",SERPINF1,Pigment epithelium-derived factor,Inverse variance weighted,15,1.00 [0.90-1.11],0.997686191440478
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,45,1.02 [0.97-1.07],0.469879958807148
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,10,1.20 [0.89-1.60],0.228568259838362
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",EDN1,Endothelin-1,Inverse variance weighted,3,0.94 [0.83-1.06],0.293637801480958
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",INHBC,Inhibin beta C chain,Inverse variance weighted,39,1.02 [0.99-1.06],0.229491810523962
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,44,1.03 [0.98-1.08],0.197364761306642
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CCL27,C-C motif chemokine 27,Inverse variance weighted,12,1.03 [0.85-1.26],0.748920832967368
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",SPON2,Spondin-2,Inverse variance weighted,8,0.91 [0.83-1.01],0.0713550003642802
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,1.02 [0.83-1.25],0.868075979371059
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1.11 [1.02-1.21],0.021162837047222
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,Inverse variance weighted,5,0.94 [0.78-1.14],0.533429550041656
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",RTN4R,Reticulon-4 receptor,Inverse variance weighted,26,1.03 [0.95-1.11],0.475649571995565
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",FSTL3,Follistatin-related protein 3,Inverse variance weighted,7,0.89 [0.76-1.04],0.14602163438357
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,37,1.01 [0.97-1.05],0.753201271545276
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",FAM3C,Protein FAM3C,Inverse variance weighted,5,1.15 [0.91-1.46],0.249525527734261
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CTSB,Cathepsin B,Inverse variance weighted,50,1.03 [0.98-1.08],0.280143876823636
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,0.94 [0.75-1.17],0.560144262224265
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,Inverse variance weighted,4,1.00 [0.84-1.20],0.96987806981153
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,31,0.98 [0.92-1.04],0.432857306919532
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",BST2,Bone marrow stromal antigen 2,Inverse variance weighted,27,1.04 [0.95-1.15],0.382024023525666
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",ITGA11,Integrin alpha-11,Inverse variance weighted,16,1.09 [0.98-1.22],0.11117993481756
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CST3,Cystatin-C,Inverse variance weighted,13,1.03 [0.96-1.12],0.410877337389
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",LGALS4,Galectin-4,Inverse variance weighted,19,0.91 [0.84-0.98],0.0104505428786769
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",UPB1,Beta-ureidopropionase,Inverse variance weighted,4,1.32 [0.91-1.92],0.145371869165763
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",HSPB6,Heat shock protein beta-6,Inverse variance weighted,5,1.29 [0.80-2.08],0.304166188218318
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,Inverse variance weighted,44,1.03 [0.98-1.09],0.27840497285171
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,25,0.97 [0.90-1.04],0.367955857257498
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,9,1.10 [0.95-1.27],0.214411064566121
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",GLA,Alpha-galactosidase A,Inverse variance weighted,2,0.87 [0.54-1.40],0.566234279028182
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",GAST,Gastrin,Inverse variance weighted,9,0.92 [0.80-1.07],0.284797012542098
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,15,0.98 [0.90-1.06],0.561561638148434
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CCL21,C-C motif chemokine 21,Inverse variance weighted,19,0.91 [0.81-1.01],0.0736944649854108
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",PTN,Pleiotrophin,Inverse variance weighted,7,1.01 [0.85-1.21],0.869101890130163
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",PLTP,Phospholipid transfer protein,Inverse variance weighted,30,1.00 [0.94-1.07],0.987331800474693
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,9,0.86 [0.75-0.99],0.0338617130541571
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",REG1A,Lithostathine-1-alpha,Inverse variance weighted,26,0.99 [0.93-1.05],0.754616833588099
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",KRT18,"Keratin, type I cytoskeletal 18",Inverse variance weighted,8,1.16 [0.99-1.35],0.0646126513144217
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,0.91 [0.71-1.17],0.461012640955687
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",Inverse variance weighted,4,0.85 [0.71-1.00],0.0535837731278343
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,15,0.98 [0.90-1.07],0.611806235516854
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,13,0.98 [0.83-1.17],0.851370268579524
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",OCLN,Occludin,Inverse variance weighted,3,0.93 [0.77-1.12],0.424136096072571
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,34,1.17 [1.02-1.33],0.0216545059064229
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,37,1.11 [1.01-1.21],0.0259045255184831
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,29,0.95 [0.91-1.00],0.0674728179888053
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CBLIF,Cobalamin binding intrinsic factor,Inverse variance weighted,59,1.01 [0.97-1.05],0.643545192024284
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,0.95 [0.90-1.00],0.0586364339658472
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,6,0.98 [0.85-1.12],0.731772944178157
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,9,0.90 [0.74-1.09],0.267118381224972
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,19,0.99 [0.92-1.06],0.812208510730567
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",TGFA,Protransforming growth factor alpha,Inverse variance weighted,11,0.94 [0.80-1.10],0.406492699161799
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,19,1.04 [0.95-1.13],0.404905298124265
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,22,1.03 [0.94-1.12],0.568599797327736
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CSTB,Cystatin-B,Inverse variance weighted,25,1.00 [0.94-1.05],0.92219377435365
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",NPPB,Natriuretic peptides B,Inverse variance weighted,3,0.89 [0.77-1.02],0.100340164318704
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",UMOD,Uromodulin,Inverse variance weighted,62,1.01 [0.97-1.05],0.653852495190557
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,19,1.02 [0.96-1.08],0.546858309990149
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,11,1.02 [0.83-1.25],0.88224587343129
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",GCG,Pro-glucagon,Inverse variance weighted,2,0.69 [0.46-1.04],0.0779797808396989
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,1.18 [0.93-1.49],0.174370298408699
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",LGALS9,Galectin-9,Inverse variance weighted,39,0.97 [0.92-1.02],0.2738711758749
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",PLG,Plasminogen,Inverse variance weighted,23,1.00 [0.90-1.11],0.982870869896293
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",FAM20A,Pseudokinase FAM20A,Inverse variance weighted,21,1.05 [0.94-1.18],0.357292972582751
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,16,1.05 [0.95-1.16],0.310249778426444
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,Inverse variance weighted,22,1.02 [0.96-1.07],0.580312585202203
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,5,1.07 [0.93-1.23],0.365928934865298
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,4,0.93 [0.78-1.10],0.398069047251485
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",GPRC5C,G-protein coupled receptor family C group 5 member C,Inverse variance weighted,7,0.95 [0.81-1.12],0.575308208603205
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",AGRP,Agouti-related protein,Inverse variance weighted,20,1.16 [0.96-1.40],0.123764199043618
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,12,0.94 [0.85-1.04],0.25801077715366
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",SOST,Sclerostin,Inverse variance weighted,31,1.02 [0.93-1.11],0.718865317520914
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,39,1.03 [0.98-1.08],0.247861805523241
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,8,1.05 [0.93-1.18],0.421550270117016
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CTSD,Cathepsin D,Inverse variance weighted,24,1.11 [1.04-1.19],0.0030331122717226
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",SERPIND1,Heparin cofactor 2,Inverse variance weighted,35,0.87 [0.80-0.95],0.002162923119765
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,10,0.94 [0.78-1.12],0.476194651004264
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",SHISA5,Protein shisa-5,Inverse variance weighted,16,0.93 [0.79-1.09],0.366862149581961
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",LAYN,Layilin,Inverse variance weighted,23,0.99 [0.92-1.07],0.811301292077981
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,1.02 [0.97-1.07],0.356759348540577
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,7,0.96 [0.87-1.06],0.405720498582882
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",MVK,Mevalonate kinase,Inverse variance weighted,3,0.80 [0.60-1.05],0.107323802652099
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",EFNA4,Ephrin-A4,Inverse variance weighted,5,1.09 [0.90-1.33],0.373255042056567
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CCL17,C-C motif chemokine 17,Inverse variance weighted,35,0.95 [0.91-1.00],0.0365869614795911
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",TFF3,Trefoil factor 3,Inverse variance weighted,10,0.90 [0.80-1.02],0.10899858839674
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,18,1.05 [0.97-1.14],0.187257725003306
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,13,0.94 [0.84-1.06],0.330713566724955
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",ELN,Elastin,Inverse variance weighted,12,1.12 [0.80-1.57],0.514084080897359
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,9,0.99 [0.87-1.11],0.811593045027352
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,12,1.16 [1.01-1.33],0.0297853988628219
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CD83,CD83 antigen,Inverse variance weighted,19,0.99 [0.88-1.11],0.847719035929169
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,0.93 [0.83-1.05],0.244586835114565
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",GRPEL1,"GrpE protein homolog 1, mitochondrial",Inverse variance weighted,3,0.96 [0.73-1.26],0.765545828071845
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",GRN,Progranulin,Inverse variance weighted,46,1.12 [1.05-1.20],0.0004704901182295
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,0.96 [0.84-1.10],0.529334958306273
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,30,1.02 [0.94-1.10],0.714297098895695
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,8,1.13 [0.88-1.44],0.341083780118588
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,6,1.17 [0.96-1.43],0.113556952787356
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",NFASC,Neurofascin,Inverse variance weighted,19,0.90 [0.84-0.97],0.004748963330279
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,13,1.53 [1.34-1.75],3.92207695679362e-10
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,23,0.96 [0.88-1.05],0.35190680130239
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",PLAT,Tissue-type plasminogen activator,Inverse variance weighted,6,0.93 [0.76-1.14],0.475175857617031
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",PENK,Proenkephalin-A,Inverse variance weighted,21,1.04 [0.97-1.11],0.31733878481681
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",TNFSF11,Tumor necrosis factor ligand superfamily member 11,Inverse variance weighted,20,0.99 [0.90-1.08],0.78726415092761
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",PALM2,Paralemmin-2,Inverse variance weighted,9,1.10 [0.99-1.22],0.072019053195145
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",MFGE8,Lactadherin,Inverse variance weighted,26,1.11 [1.00-1.24],0.0495128943663805
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",GPR37,Prosaposin receptor GPR37,Inverse variance weighted,62,1.00 [0.94-1.06],0.922027920395847
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CCN3,CCN family member 3,Inverse variance weighted,20,1.02 [0.94-1.10],0.629119572919661
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",AREG,Amphiregulin,Inverse variance weighted,7,0.89 [0.77-1.03],0.123429939680403
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",PROC,Vitamin K-dependent protein C,Inverse variance weighted,44,1.01 [0.95-1.07],0.815879638379206
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,31,0.98 [0.87-1.11],0.733920897037048
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",MUC13,Mucin-13,Inverse variance weighted,13,0.90 [0.82-1.00],0.0438278533608972
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",FGF21,Fibroblast growth factor 21,Inverse variance weighted,4,1.11 [0.93-1.32],0.267058210786443
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,0.99 [0.84-1.17],0.911881052636474
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",RBP5,Retinol-binding protein 5,Inverse variance weighted,5,1.14 [0.89-1.46],0.296964569870126
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CCL7,C-C motif chemokine 7,Inverse variance weighted,14,0.95 [0.85-1.07],0.388944087470874
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",OGN,Mimecan,Inverse variance weighted,37,0.99 [0.94-1.05],0.813399592852074
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,25,1.03 [0.92-1.15],0.590219587841596
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",NPY,Pro-neuropeptide Y,Inverse variance weighted,18,1.12 [0.95-1.32],0.169191559987322
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",GOLM2,Protein GOLM2,Inverse variance weighted,14,1.16 [1.04-1.29],0.0090860411878263
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,1.05 [0.87-1.27],0.603663583930602
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,17,1.42 [0.99-2.02],0.0539877333337247
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",RNASET2,Ribonuclease T2,Inverse variance weighted,25,1.00 [0.95-1.06],0.873443413929423
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",F9,Coagulation factor IX,Inverse variance weighted,3,0.99 [0.72-1.37],0.946687700170175
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",HGF,Hepatocyte growth factor,Inverse variance weighted,7,1.11 [0.92-1.34],0.273914631214427
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CCL15,C-C motif chemokine 15,Inverse variance weighted,28,1.00 [0.97-1.04],0.938544184935818
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,53,1.02 [0.97-1.07],0.471287960003182
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",NPL,N-acetylneuraminate lyase,Inverse variance weighted,16,0.98 [0.90-1.07],0.633633032640887
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",PRSS8,Prostasin,Inverse variance weighted,19,1.03 [0.93-1.15],0.535832292010596
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,17,1.04 [0.96-1.12],0.37029413199418
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",MMP12,Macrophage metalloelastase,Inverse variance weighted,21,1.00 [0.96-1.04],0.97128934577087
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",AMBP,Protein AMBP,Inverse variance weighted,5,1.16 [0.87-1.55],0.30221231498809
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",TFF2,Trefoil factor 2,Inverse variance weighted,16,0.98 [0.83-1.15],0.791253593454584
